ISCO
International Stem Cell CORP
Key Financials
Net Income
$-418000
↓ 100.0%
EPS (Diluted)
$-0.05
↓ 66.7%
Revenue
$9.1M
↑ 0.2%
Total Assets
$4.8M
↓ 6.8%
Operating Income
$-267000
↓ 292.6%
Total Liabilities
$4.6M
↓ 4.7%
Cash & Equivalents
$304000.00
↑ 176.4%
Shareholders' Equity
$-4060000.00
↓ 3.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 11/18/2025 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
| 8-K | 9/16/2025 | View on SEC |
| 10-Q | 8/14/2025 | View on SEC |
| 4 | 6/20/2025 | View on SEC |
| 4 | 6/20/2025 | View on SEC |
| 10-Q | 5/14/2025 | View on SEC |
| ARS | 4/24/2025 | View on SEC |
| DEF 14A | 4/24/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ISCO |
| Company Name | International Stem Cell CORP |
| CIK | 1355790 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 760-940-6383 |